Enhanced Rodeferin Broad Spectrum

Abstract

This process manufactures a finished medicine that can be used against broad spectrum, Anti-Viral, Anti-Bacterial, Anti-Fungal, and Anti-parasitic disease conditions that attack the human body but not limited to other medical conditions and or other types of treatments use for animals other than humans.

I claim: 
     
         1 . A medicine for treating disease, comprising:
 (a) a colloid;   (b) a lipid bilayer material; and   (c) methylthioninium chloride;   (d) where the lipid bilayer material wraps around the colloid.   
     
     
         2 . The medicine for treating disease presented in  claim 1 ,
 (a) wherein the colloid further comprises: colloid particles;   (b) where the colloid particles are selected from one or more of the group consisting of Silver, Gold, Silica, Copper, Zinc, Iodine, Titanium, Platinum, Palladium, Iridium, Rhodium, Osmium, Iron, and Manganese.   
     
     
         3 . The medicine for treating disease presented in  claim 2 ,
 (a) where the colloid particles range between 10 to 100 nm in size.   
     
     
         4 . The medicine for treating disease presented in  claim 3 ,
 (a) where the colloid particles in the colloid are 20 to 300 ppm.   
     
     
         5 . The medicine for treating disease presented in  claim 3 ,
 (a) where the colloid ranges from 5% to 95% by volume in the medicine.   
     
     
         6 . The medicine for treating disease presented in  claim 5 ,
 (a) where the methylthioninium chloride ranges from 0.00125% to 1.9% by weight in the medicine.   
     
     
         7 . A medicine for treating disease, comprising:
 (a) a colloid, the colloid comprising:
 (i) colloid particles; 
 (ii) where the colloid particles consist of Silver, Gold, and Silica; 
   (b) a lipid bilayer material; and   (c) methylthioninium chloride;   (d) where the lipid bilayer material wraps around the colloid.   
     
     
         8 . The medicine for treating disease presented in  claim 7 ,
 (a) where the colloid particles range between 10 to 100 nm in size.   
     
     
         9 . The medicine for treating disease presented in  claim 8 ,
 (a) where the colloid particles in the colloid are 20 to 300 ppm.   
     
     
         10 . The medicine for treating disease presented in  claim 8 ,
 (a) where the colloid ranges from 5% to 95% by volume in the medicine.   
     
     
         11 . the medicine for treating disease presented in  claim 10 ,
 (a) where the methylthioninium chloride ranges from 0.00125% to 1.9% by weight in the medicine.